
COMPASS Pathways plc
CMPSHealthcare|Biotechnology|GB
$8.61
+0.80 (+10.24%)
DCF Value
$1.38
Tangible Book / Share
$1.02
Cash / Share
$3.20
Ownership Breakdown
98.5%
Float
141.5M
Shares Outstanding
139.4M
Float Shares
Major Holders (39)
Combined: 147.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Deep Track Capital, LP | IA, OO | 9.99% | 9,274,589 | Jan 17, 2025 | 13D/G |
| Deep Track Biotechnology Master Fund, Ltd. | Corporation | 9.99% | 9,274,589 | Jan 17, 2025 | 13D/G |
| David Kroin | HC, IN | 9.99% | 9,274,589 | Jan 17, 2025 | 13D/G |
| Roderick Wong | HC, IN | 9.90% | 12,971,571 | May 15, 2026 | 13D/G |
| RTW Investments, LP | IA, PN | 9.90% | 12,971,571 | May 15, 2026 | 13D/G |
| Roderick Wong, M.D. | HC, IN | 8.30% | 7,877,349 | May 15, 2025 | 13D/G |
| ATAI Life Sciences AG | Corporation | 7.50% | 6,905,774 | Mar 5, 2025 | 13D/G |
| ATAI Life Sciences N.V. | Corporation | 6.00% | 5,785,774 | Oct 29, 2025 | 13D/G |
| BIT Capital GmbH | Non-US institution | 5.90% | 8,148,280 | Oct 28, 2026 | 13D/G |
| AtaiBeckley Inc. | Corporation | 4.96% | 4,764,710 | Feb 17, 2026 | 13D/G |
| Chen Yu | Individual | 3.90% | 3,858,000 | Aug 14, 2025 | 13D/G |
| Nantahala Capital Management, LLC | Investment adviser | 3.57% | 3,484,315 | Nov 14, 2025 | 13D/G |
| Wilmot B. Harkey | Holding company | 3.57% | 3,484,315 | Nov 14, 2025 | 13D/G |
| Daniel Mack | Holding company | 3.57% | 3,484,315 | Nov 14, 2025 | 13D/G |
| Paradigm BioCapital International Fund Ltd. | Corporation | 3.30% | 2,320,000 | Nov 14, 2024 | 13D/G |
| Paradigm BioCapital Advisors LP | Partnership | 3.30% | 2,320,000 | Nov 14, 2024 | 13D/G |
| Senai Asefaw, M.D. | Individual | 3.30% | 2,320,000 | Nov 14, 2024 | 13D/G |
| Paradigm BioCapital Advisors GP LLC | Other | 3.30% | 2,320,000 | Nov 14, 2024 | 13D/G |
| Vivo Opportunity, LLC | Other | 3.20% | 3,174,494 | Nov 14, 2025 | 13D/G |
| Vivo Opportunity Fund Holdings, L.P. | Partnership | 3.20% | 3,174,494 | Nov 14, 2025 | 13D/G |
| Israel A. Englander | Individual | 3.00% | 2,773,521 | May 7, 2025 | 13D/G |
| Millennium Group Management LLC | Other | 3.00% | 2,773,521 | May 7, 2025 | 13D/G |
| Millennium Management LLC | Other | 3.00% | 2,773,521 | May 7, 2025 | 13D/G |
| TCG Crossover Fund II, L.P. | Partnership | 2.90% | 2,893,500 | Aug 14, 2025 | 13D/G |
| TCG Crossover GP II, LLC | Other | 2.90% | 2,893,500 | Aug 14, 2025 | 13D/G |
| George Jay Goldsmith | Individual | 2.40% | 2,239,822 | Apr 15, 2025 | 13D/G |
| Ekaterina Malievskaia | Individual | 2.30% | 2,158,286 | Apr 15, 2025 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 2.10% | 1,954,896 | May 7, 2025 | 13D/G |
| Kenneth Griffin | HC, IN | 1.70% | 1,166,576 | Feb 14, 2025 | 13D/G |
| Citadel Advisors LLC | IA, HC, OO | 1.30% | 899,165 | Feb 14, 2025 | 13D/G |
| Citadel Advisors Holdings LP | HC, PN | 1.30% | 899,165 | Feb 14, 2025 | 13D/G |
| Citadel GP LLC | HC, OO | 1.30% | 899,165 | Feb 14, 2025 | 13D/G |
| TCG Crossover Fund I, L.P. | Partnership | 1.00% | 964,500 | Aug 14, 2025 | 13D/G |
| TCG Crossover GP I, LLC | Other | 1.00% | 964,500 | Aug 14, 2025 | 13D/G |
| Citadel Securities GP LLC | HC, OO | 0.40% | 267,411 | Feb 14, 2025 | 13D/G |
| Citadel Securities LLC | BD, OO | 0.40% | 267,411 | Feb 14, 2025 | 13D/G |
| Citadel Securities Group LP | HC, PN | 0.40% | 267,411 | Feb 14, 2025 | 13D/G |
| Vivo Opportunity Cayman, LLC | Other | 0.20% | 187,891 | Nov 14, 2025 | 13D/G |
| Vivo Opportunity Cayman Fund, L.P. | Partnership | 0.20% | 187,891 | Nov 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,195,987 acquired · 41,522 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nath Kabir | director, officer: Chief Executive Officer | Aug 3, 2026 | TAX W/H | 5,962 | $11.25 | $67.1K | Form 4 |
| Karydas Daphne | director | May 27, 2026 | AWARD | 21,110 | $11.85 | $250.2K | Form 4 |
| SANTINI GINO | director | May 27, 2026 | AWARD | 30,158 | $11.85 | $357.4K | Form 4 |
| Gover Justin D. | director | May 27, 2026 | AWARD | 21,110 | $11.85 | $250.2K | Form 4 |
| JONAS JEFFREY M | director | May 27, 2026 | AWARD | 21,110 | $11.85 | $250.2K | Form 4 |
| Riley Wayne Joseph | director | May 27, 2026 | AWARD | 21,110 | $11.85 | $250.2K | Form 4 |
| McQuade Robert | director | May 27, 2026 | AWARD | 21,110 | $11.85 | $250.2K | Form 4 |
| Norton David Y | director | May 27, 2026 | AWARD | 21,110 | $11.85 | $250.2K | Form 4 |
| Tregoning Kathleen | director | May 27, 2026 | AWARD | 41,119 | $11.85 | $487.3K | Form 4 |
| Tregoning Kathleen | director: | May 27, 2026 | OTHER | 0 | — | — | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Mar 26, 2026 | AWARD | 367,815 | $5.64 | $2.1M | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Mar 26, 2026 | AWARD | 175,000 | — | — | Form 4 |
| Goodwin Guy | Chief Medical Officer | Mar 26, 2026 | AWARD | 115,600 | $5.64 | $652.0K | Form 4 |
| Goodwin Guy | Chief Medical Officer | Mar 26, 2026 | AWARD | 55,000 | $0.01 | $550.00 | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 26, 2026 | AWARD | 157,635 | $5.64 | $889.1K | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 26, 2026 | AWARD | 75,000 | — | — | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Mar 11, 2026 | TAX W/H | 13,131 | $6.89 | $90.5K | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 11, 2026 | TAX W/H | 1,781 | $6.89 | $12.3K | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 2, 2026 | TAX W/H | 4,467 | $7.02 | $31.4K | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Feb 2, 2026 | TAX W/H | 16,181 | $6.61 | $107.0K | Form 4 |
| JONAS JEFFREY M | director | Oct 29, 2025 | AWARD | 52,000 | $6.33 | $329.2K | Form 4 |
| JONAS JEFFREY M | director: | Oct 29, 2025 | OTHER | 0 | — | — | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Aug 1, 2025 | TAX W/H | 6,366 | $4.34 | $27.6K | Form 4 |
| Gover Justin D. | director | Jul 29, 2025 | AWARD | 52,000 | $4.29 | $223.1K | Form 4 |
| Gover Justin D. | director: | Jul 29, 2025 | OTHER | 0 | — | — | Form 4 |
| SANTINI GINO | director | Jun 12, 2025 | AWARD | 39,000 | $4.52 | $176.3K | Form 4 |
| Riley Wayne Joseph | director | Jun 12, 2025 | AWARD | 26,000 | $4.52 | $117.5K | Form 4 |
| Norton David Y | director | Jun 12, 2025 | AWARD | 26,000 | $4.52 | $117.5K | Form 4 |
| McQuade Robert | director | Jun 12, 2025 | AWARD | 26,000 | $4.52 | $117.5K | Form 4 |
| McGoldrick Linda | director | Jun 12, 2025 | AWARD | 26,000 | $4.52 | $117.5K | Form 4 |
| Lonngren Thomas | director | Jun 12, 2025 | AWARD | 26,000 | $4.52 | $117.5K | Form 4 |
| Karydas Daphne | director | Jun 12, 2025 | AWARD | 26,000 | $4.52 | $117.5K | Form 4 |
| Jenkins Annalisa | director | Jun 12, 2025 | AWARD | 26,000 | $4.52 | $117.5K | Form 4 |
| Goodwin Guy | Chief Medical Officer | Mar 11, 2025 | AWARD | 63,000 | $3.60 | $226.8K | Form 4 |
| Goodwin Guy | Chief Medical Officer | Mar 11, 2025 | AWARD | 32,000 | $0.01 | $320.00 | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 11, 2025 | AWARD | 25,000 | — | — | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 11, 2025 | AWARD | 76,000 | $3.60 | $273.6K | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Mar 11, 2025 | AWARD | 275,000 | $3.60 | $990.0K | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Mar 11, 2025 | AWARD | 92,000 | — | — | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 3, 2025 | TAX W/H | 4,468 | $3.67 | $16.4K | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Feb 3, 2025 | TAX W/H | 15,516 | $4.31 | $66.9K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Oct 24, 2024 | SELL | 776,565 | — | — | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Oct 24, 2024 | SELL | 776,565 | — | — | Form 4 |
| Goldsmith George Jay | 10 percent owner | Oct 24, 2024 | SELL | 776,565 | — | — | Form 4 |
| Goldsmith George Jay | 10 percent owner | Oct 24, 2024 | SELL | 776,565 | — | — | Form 4 |
| ATAI Life Sciences N.V. | 10 percent owner | Sep 26, 2024 | SELL | 2,660,000 | $6.05 | $16.1M | Form 4 |
| SANTINI GINO | director | Sep 3, 2024 | AWARD | 52,000 | $7.22 | $375.4K | Form 4 |
| SANTINI GINO | director: | Sep 3, 2024 | OTHER | 0 | — | — | Form 4 |
| Jenkins Annalisa | director | Aug 1, 2024 | TAX W/H | 161 | $6.88 | $1.1K | Form 4 |
| Nath Kabir | director, officer: Chief Executive Officer | Aug 1, 2024 | TAX W/H | 7,064 | $6.88 | $48.6K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | May 20, 2024 | SELL | 6,703 | $7.89 | $52.9K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | May 20, 2024 | SELL | 6,704 | $7.89 | $52.9K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | May 21, 2024 | SELL | 8,900 | $7.91 | $70.4K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | May 21, 2024 | SELL | 8,900 | $7.91 | $70.4K | Form 4 |
| Goldsmith George Jay | 10 percent owner | May 20, 2024 | SELL | 6,703 | $7.89 | $52.9K | Form 4 |
| Goldsmith George Jay | 10 percent owner | May 20, 2024 | SELL | 6,704 | $7.89 | $52.9K | Form 4 |
| Goldsmith George Jay | 10 percent owner | May 21, 2024 | SELL | 8,900 | $7.91 | $70.4K | Form 4 |
| Goldsmith George Jay | 10 percent owner | May 21, 2024 | SELL | 8,900 | $7.91 | $70.4K | Form 4 |
| Riley Wayne Joseph | director | May 9, 2024 | AWARD | 26,000 | $8.54 | $222.0K | Form 4 |
| Lonngren Thomas | director | May 9, 2024 | AWARD | 26,000 | $8.54 | $222.0K | Form 4 |
| McGoldrick Linda | director | May 9, 2024 | AWARD | 26,000 | $8.54 | $222.0K | Form 4 |
| Jenkins Annalisa | director | May 9, 2024 | AWARD | 26,000 | $8.54 | $222.0K | Form 4 |
| McQuade Robert | director | May 9, 2024 | AWARD | 26,000 | $8.54 | $222.0K | Form 4 |
| Karydas Daphne | director | May 9, 2024 | AWARD | 26,000 | $8.54 | $222.0K | Form 4 |
| Norton David Y | director | May 9, 2024 | AWARD | 39,000 | $8.54 | $333.1K | Form 4 |
| Goldsmith George Jay | 10 percent owner | May 2, 2024 | SELL | 9,621 | $8.29 | $79.8K | Form 4 |
| Goldsmith George Jay | 10 percent owner | May 2, 2024 | SELL | 9,622 | $8.29 | $79.8K | Form 4 |
| Goldsmith George Jay | 10 percent owner | May 3, 2024 | SELL | 18,762 | $8.82 | $165.5K | Form 4 |
| Goldsmith George Jay | 10 percent owner | May 3, 2024 | SELL | 18,761 | $8.82 | $165.4K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | May 2, 2024 | SELL | 9,621 | $8.29 | $79.8K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | May 2, 2024 | SELL | 9,622 | $8.29 | $79.8K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | May 3, 2024 | SELL | 18,762 | $8.82 | $165.5K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | May 3, 2024 | SELL | 18,761 | $8.82 | $165.4K | Form 4 |
| Jenkins Annalisa | director | May 1, 2024 | TAX W/H | 211 | $8.48 | $1.8K | Form 4 |
| Goldsmith George Jay | 10 percent owner | Apr 16, 2024 | SELL | 23,881 | $8.53 | $203.7K | Form 4 |
| Goldsmith George Jay | 10 percent owner | Apr 16, 2024 | SELL | 23,880 | $8.53 | $203.7K | Form 4 |
| Goldsmith George Jay | 10 percent owner | Apr 17, 2024 | SELL | 10,850 | $8.78 | $95.3K | Form 4 |
| Goldsmith George Jay | 10 percent owner | Apr 17, 2024 | SELL | 10,850 | $8.78 | $95.3K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Apr 16, 2024 | SELL | 23,881 | $8.53 | $203.7K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Apr 16, 2024 | SELL | 23,880 | $8.53 | $203.7K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Apr 17, 2024 | SELL | 10,850 | $8.78 | $95.3K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Apr 17, 2024 | SELL | 10,850 | $8.78 | $95.3K | Form 4 |
| Goldsmith George Jay | 10 percent owner | Apr 1, 2024 | SELL | 25,750 | $8.96 | $230.7K | Form 4 |
| Goldsmith George Jay | 10 percent owner | Apr 1, 2024 | SELL | 25,750 | $8.96 | $230.7K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Apr 1, 2024 | SELL | 25,750 | $8.96 | $230.7K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Apr 1, 2024 | SELL | 25,750 | $8.96 | $230.7K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Mar 28, 2024 | SELL | 25,750 | $8.65 | $222.8K | Form 4 |
| Malievskaia Ekaterina | 10 percent owner | Mar 28, 2024 | SELL | 25,750 | $8.65 | $222.8K | Form 4 |
| Goldsmith George Jay | 10 percent owner | Mar 28, 2024 | SELL | 25,750 | $8.65 | $222.8K | Form 4 |
| Goldsmith George Jay | 10 percent owner | Mar 28, 2024 | SELL | 25,750 | $8.65 | $222.8K | Form 4 |
| Goldsmith George Jay | director, 10 percent owner: | Mar 12, 2024 | SELL | 15,740 | $10.58 | $166.5K | Form 4 |
| Goldsmith George Jay | director, 10 percent owner: | Mar 12, 2024 | SELL | 15,740 | $10.58 | $166.5K | Form 4 |
| Goldsmith George Jay | director, 10 percent owner: | Mar 13, 2024 | SELL | 17,203 | $10.80 | $185.9K | Form 4 |
| Goldsmith George Jay | director, 10 percent owner: | Mar 13, 2024 | SELL | 17,203 | $10.80 | $185.9K | Form 4 |
| Malievskaia Ekaterina | director, 10 percent owner: | Mar 12, 2024 | SELL | 15,740 | $10.58 | $166.5K | Form 4 |
| Malievskaia Ekaterina | director, 10 percent owner: | Mar 12, 2024 | SELL | 15,740 | $10.58 | $166.5K | Form 4 |
| Malievskaia Ekaterina | director, 10 percent owner: | Mar 13, 2024 | SELL | 17,203 | $10.80 | $185.9K | Form 4 |
| Malievskaia Ekaterina | director, 10 percent owner: | Mar 13, 2024 | SELL | 17,203 | $10.80 | $185.9K | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 1, 2024 | AWARD | 117,643 | $11.48 | $1.4M | Form 4 |
| Loxam Teri | Chief Financial Officer | Mar 1, 2024 | AWARD | 62,718 | — | — | Form 4 |